Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma
Radiation therapy has a well-established role in the treatment of Hodgkin's Disease and non-Hodgkin's Lymphoma. With technological developments, 3-D Dimensional (3D) planning has evolved as a highly precise treatment planning option. High-precision radiation therapy has the potential for more accurate dose delivery to the tumour volume and can result in a greater sparing of normal tissue. An important component of safe radiotherapy delivery is the feasibility and reproducibility of current and new immobilization devices for highly conformal treatment.
The purpose of this study is to determine the reproducibility of an immobilization device known as BodyFIX(TM) using conventional treatment techniques.
|Hodgkin's Disease Lymphoma, Non-Hodgkin||Device: BodyFIX||Phase 1 Phase 2|
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||A Study to Examine the Reproducibility of an Immobilization Device (BodyFIX ) to Deliver High Precision Radiation Therapy for Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00232440
|University Health Network|
|Toronto, Ontario, Canada, M5G 2M9|
|Principal Investigator:||Alex Sun, MD||Princess Margaret Hospital, Canada|